Home Veru

Veru

In operation
IPO
Tumor Biopharmaceutical Manufacturer
Basic
Enterprise Profile

Basic Information

Veru is an oncology biopharmaceutical company focused on developing new drugs for the treatment of breast cancer and prostate cancer. Our strategy is primarily centered on the clinical development and commercialization of oncology drugs to treat the two most prevalent cancers globally—breast cancer and prostate cancer.
Veru, Inc.
Miami,Florida,United States of America
101~500 people
January 01, 1896
info@veruhealthcare.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Urology Department Obstetrics and Gynecology Therapeutic Products Breast Cancer Prostate Cancer
Application Scenarios
Innovative Drugs